A nurse prepares the Pfizer-BioNTech Covid-19 vaccine at Clarendon McLeod Health Hospitals in Manning, South Carolina.
Photographer: Micah Green / Bloomberg
Photographer: Micah Green / Bloomberg
Some U.S. states say the federal government is on their rations of the Pfizer Inc.-BioNTech SE Covid-19 vaccine for next week unexplained.
Oregon’s share of Pfizer doses for next week was cut by 40%, Governor Kate Brown said in her tweet Thursday afternoon. Washington state had expected more than 74,000 doses of the picture for next week, but received word from Operation Warp Speed, the U.S. vaccine development program, that the state would receive 44,850 instead.
“This was a federal decision,” Brown wrote of her state cut in a different way tweet, “And I am seeking responses from the CDC on the reliability of the data we receive from week to week as Oregon builds our vaccine circulation plan. ”
Operation Warp Speed has said that 2 million doses of Pfizer ‘s design will go out next week, in addition to the 2.9 million that were released this week. Second vaccine developed by Moderna Inc. went. recommended by an advisory panel to the Food and Drug Administration on Thursday. Officials said this week that 5.9 million doses of the Moderna could be dispensed next week if, as expected, the FDA will soon approve emergency use of the vaccine.
Read More: Over 1.1 million vaccinated: Covid-19 Tracker
Before the Pfizer vaccine began to be released this week, states were reporting widespread upheaval and frequently changing estimates for how many doses they should expect. “We have not been given an explanation for why our allocation has been reduced, and we do not currently have satisfaction numbers beyond next week,” Washington state said in a statement late Thursday.
Operation Warp Speed did not immediately respond to a request for comment Friday.
“It’s a little frustrating because they’re trying to design,” said Marcus Plescia, chief medical officer for the Association of State and Territorial Health Officers, the professional body for state public health directors. He said some lumps of supply are understandable because of its complexity, but said the government should be clearer.
– Supported by Angelica LaVito